These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12497591)

  • 1. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.
    Warzynski MJ; Graham DM; Axtell RA; Higgins JV; Hammers YA
    Cytometry; 2002 Dec; 50(6):298-304. PubMed ID: 12497591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
    Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
    Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
    Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
    Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
    Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
    Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
    Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
    Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow.
    Okcu MF; Wang RY; Bueso-Ramos C; Schober W; Weidner D; Andrassy R; Blakely M; Russell H; Ozkan A; Kuttesch J; Andreeff M; Chan KW; Ater J
    Pediatr Blood Cancer; 2005 Nov; 45(6):787-95. PubMed ID: 15929127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
    Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
    Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
    Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
    Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and atypical neuroblastoma--case reports.
    Csáthy L; Kappelmayer J; Szegedi I; Kajtár B; Kiss C; Hevessy Z
    Cytometry B Clin Cytom; 2011 Mar; 80(2):134-6. PubMed ID: 21337495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
    Farinola MA; Weir EG; Ali SZ
    Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of conjugated ganglioside GD2 monoclonal antibody.
    Warzynski MJ; Roys JL; Peterson JW; DeLa Vega H
    Cytometry B Clin Cytom; 2005 May; 65(1):42-3. PubMed ID: 15806571
    [No Abstract]   [Full Text] [Related]  

  • 13. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry.
    Nagai J; Ishida Y; Koga N; Tanaka Y; Ohnuma K; Toyoda Y; Katoh A; Hayabuchi Y; Kigasawa H
    J Pediatr Hematol Oncol; 2000; 22(1):20-6. PubMed ID: 10695817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
    De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
    Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference of bone marrow CD56
    Theodorakos I; Paterakis G; Papadakis V; Vicha A; Topakas G; Jencova P; Karchilaki E; Taparkou A; Tsagarakis NJ; Polychronopoulou S
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27799. PubMed ID: 31066205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-intensity multiplexing: simultaneous seven-marker, two-color immunophenotyping using flow cytometry.
    Bradford JA; Buller G; Suter M; Ignatius M; Beechem JM
    Cytometry A; 2004 Oct; 61(2):142-52. PubMed ID: 15382027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.
    Popov A; Druy A; Shorikov E; Verzhbitskaya T; Solodovnikov A; Saveliev L; Tytgat GAM; Tsaur G; Fechina L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):535-542. PubMed ID: 30603901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.